참고문헌 (16)

1. 10.1056/NEJM199410063311402 Mayer RJ, Davis RB, Schiffer CA, Berk DT, Powell BL, Schulman P, Omura GA, Moore JO, Mcintyre OR, Frei E, for the Cancer and Leukemia Group B: Intensive postremission chemotherapy in adults with acute myeloid leukemia. New Engl. J. Med. 1994;331:896. 

   상세보기

2. Blood Bishop 87 1710 1996 10.1182/blood.V87.5.1710.1710 A randomized trial of high-dose cytarabine in acute myeloid leukemia 

   상세보기

3. 10.1016/S0145-2126(00)00075-8 Thomas X, Cambier N, Taksin AL, Reman O, Vekhoff A, Pautas C, Leblond V, Soler-Michel P, Ecstein-Fraı̈sse E, Archimbaud E. Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemia. Leuk Res 2000;11:957-963. 

   상세보기

4. Leukemia Arlin 4 177 1990 Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL) 

5. Semin. Oncol. Alberts 12 4 38 1985 In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by peritoneal administration 

6. Leukemia Grant 5 336 1991 Effect of pharmacologically relevant concentration of mitoxantrone on the in vitro growth of leukemic blast progenitors 

7. Blood Bhalla 82 3133 1993 10.1182/blood.V82.10.3133.3133 High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells 

   상세보기

8. J. Clin. Oncol. Feldman 11 2002 1993 10.1200/JCO.1993.11.10.2002 Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia 

   상세보기

9. Cancer Chemother. Rep. Yates 57 485 1973 Cytosine arabinoside (NSC-62878) and daunorubicin (NSC-83142) therapy in acute non-lymphocytic leukemia 

10. Blood Head 86 1717 1995 10.1182/blood.V86.5.1717.bloodjournal8651717 Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia 

    상세보기

11. Ann. Intern. Med. Appelbaum 101 581 1984 10.7326/0003-4819-101-5-581 Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparison 

    상세보기

12. Leukemia Feldman 11 4 485 1997 10.1038/sj.leu.2400623 A randomized trial of high- versus standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia 

    상세보기

13. Bishop JF, Lowenthal RM, Joshua D, Matthews JP, Todd D, Cobcroft R, Whiteside MG, Kronenberg H, Ma D, Dodds A, et al, Etoposide in acute nonlymphocytic leukemia. Austr. Leuk. Study Group Blood 1990;75 (1):27-32. 

14. Ann. Hematol. Strout 78 6 251 1999 10.1007/s002770050511 Core-binding factor (CBF) and MLL-associated primary acute myeloid leukemia: biology and clinical implications 

    상세보기

15. J. Clin. Oncol. Hudis 17 4 1118 1999 10.1200/JCO.1999.17.4.1118 5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: a phase II study 

    상세보기

16. New Engl. J. Med. Gianni 336 18 1290 1997 10.1056/NEJM199705013361804 High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma 

    상세보기